ACE and diabetic kidney disease: In particular, renin-angiotensin-aldosterone system (RAAS) inhibitors such as angiotensin-converting enzyme and angiotensin II receptor blockers have shown undeniable renoprotective effects, especially in proteinuric and diabetic nephropathy [92,93].